porphycene

01/01/2007 - "Some pharmacokinetic and phototherapeutic studies on experimental tumors after intravenous or topical application of lipophilic alkyl-substituted porphycene derivatives are known. "
01/17/1996 - "Photodynamic therapy as short as 5 min after injection led to complete local tumor remission at a dosage of 1.4 mumol/kg for the porphycene CBPn. "
10/01/1997 - "Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene."
01/01/2007 - "Taking into account all these features, porphycene PSs should be very useful for PDT of cancer and other biomedical applications."
01/01/2021 - "A red-light-activated sulfonamide porphycene for highly efficient photodynamic therapy against hypoxic tumor."

05/01/2005 - "The photosensitizer 9-capronyloxytetrakis (methoxyethyl) porphycene localizes predominantly in the endoplasmic reticulum (ER) and, to a lesser extent, in mitochondria of murine leukemia L1210 cells. "
12/01/2007 - "In this study, we followed the fate of mouse leukemia L1210 cells after photodamage to the endoplasmic reticulum (ER) using a porphycene photosensitizer, where Bcl-2 was among the PDT targets. "

02/01/1997 - "Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma."

08/06/2013 - "Modifications of microvascular EC surface modulate phototoxicity of a porphycene anti-ICAM-1 immunoconjugate; therapeutic implications."

07/01/2002 - "Selected bacterial strains that are responsible for periodontal diseases are efficiently inactivated by visible light irradiation in the presence of porphycene-polylysine conjugates. "
07/01/2002 - "Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates."